top of page

log inserm.png

Enabling innovation in cell and gene therapy

Check our recent publication: FAP-CAR-T cells reduce muscle fibrosis

Check our recent publication: FAP-CAR-T cells reduce muscle fibrosis

Check our recent publication: FAP-CAR-T cells reduce muscle fibrosis

Recently published in Molecular Therapy Methods and Clinical Development Click here

L’ART-TG obtient la certification ISO 9001:2015 et renforce son système de management de la qualité.

L’ART-TG obtient la certification ISO 9001:2015 et renforce son système de management de la qualité.

L’ART-TG obtient la certification ISO 9001:2015 et renforce son système de management de la qualité.

L’ART-TG , l’Accélérateur de Recherche Technologique en Thérapie Génique est fier de vous annoncer l’obtention de la certification ISO...

In the news

Expertise

dna-g624eb8017_1920 gerd altmann pixabay.jpg

Translational research in cell and gene therapy

Lentiviral vector production

About us

ART-TG is an innovation and development laboratory for cell and gene therapy, established by Inserm. Its mission is to accelerate the transfer of promising research discoveries towards clinical stages, which ultimately will ensure that the best gene therapies will be available for patients.

Anne Galy, founder of ART-TG (view her bio)

SEE MORE INFORMATION

Our projects are funded by

ART-TG is accessible by public transportation: about 400m from RER-D Bras de Fer-Genepole station

bottom of page